1 option
Clinical review report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- Hypertension--Treatment.
- Hypertension.
- Physical Description:
- 1 online resource (1 PDF file (48 pages)) : illustrations
- Other Title:
- Clinical review report Travoprost 0.003%
- Place of Publication:
- Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health, 2017.
- Summary:
- The objective of the review was to identify, summarize, and critically assess the beneficial and harmful effects of travoprost 0.003% PQ for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma(OAG).
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.